CVS Caremark Corp. (NYSE:CVS) added 22 drugs and one product (diabetes test strips) to its 2015 formulary exclusion list, bringing the total number of excluded products to 95. At least seven of the new products are also excluded by Express Scripts Holding Co. (NASDAQ:ESRX). Four are "preferred alternatives" in Express Scripts' list. (A) Being acquired by AbbVie Inc. (NYSE:ABBV); (B) CVS did not provide details